Related Experiment Video
Updated: Jun 5, 2026
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Regulatory systems for hypoxia-inducible gene expression in ischemic heart disease gene therapy
Hyun Ah Kim1, Taiyoun Rhim, Minhyung Lee
1Department of Bioengineering, College of Engineering, Hanyang University, Seoul 133-791, Republic of Korea.
Insights
Gene therapy for ischemic heart disease uses targeted gene regulation to deliver therapeutic genes only to affected heart tissue. This approach enhances treatment efficacy and minimizes harmful side effects in normal tissues.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Gene Therapy
Background:
- Ischemic heart diseases result from reduced blood flow to the heart muscle due to narrowed coronary arteries.
- Hypoxia-inducible factor-1 (HIF-1) up-regulates genes in ischemic tissue, responding to low oxygen levels.
- Current gene therapies use angiogenic and anti-apoptotic genes to improve blood supply and protect heart cells.
Purpose of the Study:
- To review advancements in gene expression systems for targeted delivery in ischemic heart disease.
- To discuss strategies for limiting therapeutic gene expression to ischemic tissues.
- To evaluate methods for enhancing gene therapy efficiency and safety.
Main Methods:
- Development and evaluation of transcriptional, post-transcriptional, and post-translational regulatory strategies.
- Testing of gene expression systems in animal models of ischemic heart disease.
- Analysis of methods to control gene expression in response to ischemic conditions.
Main Results:
- Various gene expression strategies have been developed for ischemic-specific gene delivery.
- These systems demonstrate potential to restrict therapeutic gene expression to ischemic tissues.
- Regulatory systems can improve the safety and effectiveness of gene therapy for heart conditions.
Conclusions:
- Tight regulation of gene expression is crucial to avoid adverse effects from growth factors and anti-apoptotic proteins in normal tissues.
- Ischemic-specific gene expression systems offer a promising approach to enhance gene therapy for ischemic heart diseases.
- Recent progress in regulatory strategies holds potential for more effective and safer cardiovascular treatments.
Abstract:
Ischemic heart diseases are caused by narrowed coronary arteries that decrease the blood supply to the myocardium. In the ischemic myocardium, hypoxia-responsive genes are up-regulated by hypoxia-inducible factor-1 (HIF-1). Gene therapy for ischemic heart diseases uses genes encoding angiogenic growth factors and anti-apoptotic proteins as therapeutic genes. These genes increase blood supply into the myocardium by angiogenesis and protect cardiomyocytes from cell death. However, non-specific expression of these genes in normal tissues may be harmful, since growth factors and anti-apoptotic proteins may induce tumor growth. Therefore, tight gene regulation is required to limit gene expression to ischemic tissues, to avoid unwanted side effects. For this purpose, various gene expression strategies have been developed for ischemic-specific gene expression. Transcriptional, post-transcriptional, and post-translational regulatory strategies have been developed and evaluated in ischemic heart disease animal models. The regulatory systems can limit therapeutic gene expression to ischemic tissues and increase the efficiency of gene therapy. In this review, recent progresses in ischemic-specific gene expression systems are presented, and their applications to ischemic heart diseases are discussed.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
01:31Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
01:23Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...